| Today's Open | $228.36 |
|---|---|
| Previous Close | $227.99 |
| Daily Range | $224.60 - $228.86 |
| 52-Week Range | $126.39 - $231.99 |
| Market Cap | $53.8B |
| P/E Ratio | 36.19 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,243,879 |
| Average Daily Volume | 1,334,568 |
| Current FY EPS | $7.88 |
Sector
Healthcare
Industry
Drugs
Biogen Idec (BIIB) Description
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/
News & Commentary
2 Scariest Dividend Stocks in Health Care
The yields look great, but these 2 health-care dividend stocks could be the scariest ones around in the near future.Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarte
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next QuarterDiversifying Royalties at a Hefty Cost
Elan buys 21% of Thervance's royalties on Glaxo's lung drugs.
A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.
BIIB's Top Competitors
(-0.50%)
(0.63%)
(2.44%)
